Omeros reported $-33011000 in Net Income for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acelrx Pharmaceuticals ACRX:US $ -8.67M 0.76M
Adma Biologics ADMA:US $ -25.01M 8.36M
Aerie Pharmaceuticals AERI:US $ -35.89M 81.42M
Alnylam Pharmaceuticals ALNY:US $ -240.34M 18.12M
Biomarin Pharmaceutical BMRN:US $ 120.8M 178.7M
Cytokinetics CYTK:US $ -89.44M 58.88M
Dynavax Technologies DVAX:US $ 32.86M 66.92M
Gilead Sciences GILD:US $ 19M 363M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Insmed INSM:US $ -94621000 18.36M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
Knight Therapeutics Inc GUD:CN C$ -18811000 10.51M
Macrogenics MGNX:US $ -66.44M 8.42M
Mirati Therapeutics MRTX:US $ -188.39M 11.23M
Pacira Pharmaceuticals PCRX:US $ 6.83M 11.96M
Pfizer PFE:US $ 7863M 4470M
Regulus Therapeutics RGLS:US $ -6.72M 0.41M
Sangamo Biosciences SGMO:US $ -43.98M 6.48M
Sarepta Therapeutics SRPT:US $ -105.02M 16.96M
United Therapeutics UTHR:US $ 239.9M 127.7M
Vertex Pharmaceuticals VRTX:US $ 762.1M 8.01M
Vital Therapies VTL:US $ -20.81M 0.38M
Xoma XOMA:US $ -2280000 32.12M